Please refer attached file

Date: 3rd September, 2026 BSE Limited National Stock Exchange of India Limited P. J. Towers, Dalal Street, Fort, Exchange Plaza, Bandra-Kurla Complex, Mumbai- 400 001 Bandra (East), Mumbai - 400 051 BSE scrip code: 543635 NSE Symbol: PPLPHARMA Sub: Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’) – ESG Rating Dear Sir / Madam, With reference to the captioned subject, please note that as per the information received by the Company on September 03, 2026, NSE Sustainability Ratings and Analytics Limited (‘NSE Sustainability’), has assigned an Environment, Social and Governance (‘ESG’) Rating of ‘65’ for the Company for the FY 2025-26 based on data made available by the Company in public domain for that year, marking an improvement over previous score of 64, reflecting the Company's ongoing commitment to sustainability and responsible operations. The link for the rating as published is also available on the website of NSE Sustainability - NSE Sustainability Ratings & Analytics. Please note that the Company has not engaged NSE Sustainability for ESG Rating. NSE Sustainability has voluntarily prepared the report considering the ESG factors reported by the Company. This intimation is also being uploaded on the website of the Company at https://www.piramalpharma.com/. Kindly treat this intimation for your information and record. Thank you. Yours truly, For Piramal Pharma Limited Maneesh Sharma Company Secretary & Compliance Officer Piramal Pharma Limited CIN: L24297MH2020PLC338592 Registered Office: Ananta Building, Piramal Corporate Park, Opp. Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai – 400070, Maharashtra, India Tel No. +91 22 3802 3000 / 4000; Email Id: shareholders.ppl@piramal.com www.piramalpharma.com